CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE
Post-LOEclindamycin phosphate and benzoyl peroxide
ANDATOPICALGEL
Approved
Apr 2021
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
3/8 — Basic
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE (clindamycin phosphate and benzoyl peroxide) by PharmaIN is [see clinical pharmacology ()]. First approved in 2021.
Drug data last refreshed 21h ago
Mechanism of Action
[see Clinical Pharmacology ()]. Benzoyl Peroxide Benzoyl peroxide is an oxidizing agent with bacteriocidal and keratolytic effects, but the precise mechanism of action is unknown.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Perimenstrual Acne With Clindamycin Phosphate and Benzoyl Peroxide
Started Jan 2017
22 enrolled
Actinic Keratosis
Company
PharmaIN
Worked on CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.